Answers are grounded in this paper and cite their sources.
Therapeutic system improves macrophage and Th17/Treg activity in diabetic wounds, indicating potential for enhanced healing.
In recent years, there has been a progressive increase in the cumulative number of individuals afflicted with diabetic wounds, elevating this condition to a global public health concern of significant magnitude. The disruption of the immune microenvironment is recognized as a critical factor impeding the healing process of diabetic wounds. Nevertheless, existing research has predominantly concentrated on innate immune regulation, particularly targeting macrophages, while often overlooking adaptive immunity, which plays an equally vital role within the immune microenvironment. To address both innate and adaptive immune remodeling in diabetic wounds, the CSp-OxD@Cu 2+ /G hydrogel system has been developed. This system features a dual-dynamically crosslinked structure formed through Schiff base and borate ester bonds, with Cu 2+ /G nanoparticles generated via the chelation of guaiacol with copper ions. Upon application to diabetic wounds, the hydrogel system’s self-healing and adhesive properties provide an effective physical barrier. Concurrently, the borate ester bonds gradually respond to H + in the local environment, dissociating and facilitating the slow release of Cu 2+ /G nanoparticles, thereby reprogramming macrophages and Th17/Treg cells to concurrently regulate both innate and adaptive immune processes. This therapeutic system, characterized by its comprehensive immune regulatory effects, offers a novel platform for the management of diabetic wounds.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: